Hypertension Scientific Sessions 2021

Sponsored by: Council on Hypertension and Council on Kidney in Cardiovascular Disease
NEW DATES! September 27–29, 2021 | A Virtual Event

Young male healthcare worker adjusts blood pressure cuff on the arm of an older male patient.

Hypertension 2021 new dates!

Join us virtually September 27–29, 2021

Expectations of the 2021 Program:

COH and KCVD Awards Program
Keynote Lecture
Clinical science and primary care sessions
Symposia on hot topics
Basic and translational science weighted toward presentations derived from submitted abstracts

Abstract submissions are closed

We know this has been an exceptionally challenging year in so many ways. We want to recognize all the research and clinical work that has been performed during this difficult time. Therefore, attendees can expect that the program will be dedicated to important and innovative clinical topics in hypertension as well as research performed by our members and attendees. The latter will primarily include abstract presentations.

Why You Should Attend Hypertension Scientific Sessions

Considered one of the most important medical meetings on this subject in the world, the conference includes oral and poster presentations selected from abstracts submitted by clinical and basic researchers, followed by discussions led by leading authorities. With experts in the fields of hypertension and its relationship to cardiac and kidney disease, stroke, obesity, and genetics, attendees will have the opportunity to connect with cross-disciplinary researchers from around the world.

This meeting also offers sessions specifically designed to benefit trainees and early career investigators, as well as Clinical Practice Clinical Science topics focused on applying clinical science to the clinician’s practice and Primary Care programming dedicated to practical advice for the Primary Care Provider (PCP) interested in clinical hypertension.

2021 Programming Schedule

3 Days of programming beginning 10:00 a.m. Central Time Monday

Monday, September 27 10:00 a.m. Central Time

We are excited to announce the conference will open with the recipient of the 2019 Nobel Prize in Physiology or Medicine:

Gregg L. Semenza, MD, PhD

Gregg L. Semenza, MD, PhD, Director, Vascular Program, Institute for Cell Engineering

Professor of Genetic Medicine, Johns Hopkins University, 2019 Nobel Prize in Physiology or Medicine

Presenting: Hypoxia-Inducible Factors in Physiology and Medicine.

Clinical programming all three days will include sessions on:

Hypertension Management Through the Lifespan: Children/Adolescence, Middle Age, Older Adults.
Equity in Hypertension Control: Role of Clinicians, Communities, and Health Policy
Managing BP Beyond the Physician Room: Lifestyle Interventions, Social Support, and Home Blood Pressure Monitoring
Beyond ABCD... Outpatient Management of Resistant Hypertension.
Managing Hypertension Through Telemedicine: Billing for Home Blood Pressure Monitoring and Virtual Communication
Landscape of Hypertension Clinical Trials and Future Directions for Research
Team-Based Care to Improve BP Control: What is the Dream Team?

Hypertension Trainee Advocacy committee oral abstract track

This track will highlight science submitted by early career, junior investigators. Oral sessions will be offered all three days!

All trainees with abstracts chosen for platform oral presentations will receive a Trainee Advisory Committee (TAC) Research Recognition Award covering member registration to the conference ($99 value).

Recent Advances Programming

Council on Kidney in Cardiovascular Disease Symposium: Abundant Protein with Ample Evidence- Role of Uromodulin in Hypertension, Kidney Disease, and Inflammation
Council on Hypertension Symposium: Single Cell Epigenomics and Transcriptomics

Award Lectures with Integrated Abstract Presentations

All times are Central Daylight Time (UTC -5) Monday, September 27

Monday Programming
Time	Event
10:00 a.m. CDT	Session 1: Opening remarks and Keynote Keynote: Hypoxia-Inducible Factors in Physiology and Medicine – Dr. Gregg L. Semenza, MD, PhD
11:15 a.m. CDT	Session 2A Council on Kidney in Cardiovascular Disease Symposium: Abundant Protein with Ample Evidence- Role of Uromodulin in Hypertension, Kidney Disease, and Inflammation Session 2B Trainee Advocacy Committee (TAC) Oral Abstract Presentations Session 2C Clinical Programming
12:30 p.m. CDT	Session 3A Council on Hypertension Symposium: Single Cell Epigenomics and Transcriptomics Session 3B Trainee Advocacy Committee (TAC) Oral Abstract Presentations Session 3C Clinical Programming
2:00–4:00 p.m. CDT	Moderated Poster Sessions “Meet Dr Semenza” special networking session Trainee Advocacy sessions and other networking and special sessions

All times are Central Daylight Time (UTC -5) Tuesday, September 28

Tuesday Programming
Time	Event
10:00 a.m. CDT	Session 4A The Excellence Award for Hypertension Research Lecture The Arthur C. Corcoran Memorial Lecture Session 4B Trainee Advocacy Committee (TAC) Oral Abstract Presentations Session 4C Clinical Programming
11:15 a.m. CDT	Session 5A The Donald Seldin Lecture, followed by selected oral abstract presentations Session 5B Trainee Advocacy Committee (TAC) Oral Abstract Presentations Session 5C Clinical Programming
12:30 PM CDT	Session 6A The Lewis K. Dahl Memorial Lecture, followed by selected oral abstract presentations Session 6B Trainee Advocacy Committee (TAC) Oral Abstract Presentations Session 6C Clinical Programming
2:00–4:00 p.m. CDT	Moderated Poster Sessions Trainee Advocacy sessions and other networking and special sessions

All times are Central Daylight Time (UTC -5) Wednesday, September 29

Wednesday Programming
Time	Event
10:00 a.m. CDT	Session 7A The Harriet Dustan Award Lecture, followed by selected oral abstract presentations Session 7B Trainee Advocacy Committee (TAC) Oral Abstract Presentations Session 7C Clinical Programming
11:15 a.m. CDT	Session 8A The Mid-Career Award for Research Excellence, followed by selected oral abstract presentations Session 8B Trainee Advocacy Committee (TAC) Oral Abstract Presentations Session 8C Clinical Programming
12:30 PM CDT	Session 9A The Harry Goldblatt Award for Early Career Investigators, followed by selected oral abstract presentations Session 9B Trainee Advocacy Committee (TAC) Oral Abstract Presentations Session 9C Clinical Programming
2:00–4:00 p.m. CDT	Moderated Poster Sessions Trainee Advocacy sessions and other networking and special sessions